Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20015 | 26203597 | Curr Opin Clin Nutr Metab Care | Fructose and liver function--is this behind nonalcoholic liver disease? | 2015 | Details |
| A20018 | 26202818 | Aliment Pharmacol Ther | Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study. | 2015 | Details |
| A20023 | 26201461 | Drugs | Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway. | 2015 | Details |
| A20049 | 26191218 | Int J Clin Exp Pathol | Protective effect of salvianolic acid B on NASH rat liver through restoring intestinal mucosal barrier function. | 2015 | Details |
| A20051 | 26190501 | J Gastroenterol | Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis. | 2015 | Details |
| A20069 | 26178698 | Hepatology | CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis. | 2015 | Details |
| A20083 | 26168700 | J Nutr Biochem | Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. | 2015 | Details |
| A20106 | 26151226 | Clin Biochem | Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. | 2015 | Details |
| A20118 | 26143342 | Dig Dis Sci | Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20121 | 26140087 | World J Hepatol | Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. | 2015 | Details |
| A20127 | 26138749 | Expert Rev Gastroenterol Hepatol | In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications? | 2015 | Details |
| A20133 | 26134926 | Expert Opin Drug Saf | Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect? | 2015 | Details |
| A20135 | 26133980 | Liver Int | Probe-based confocal laser endomicroscopy quantitative morphometric markers associated with portal hypertension in duodenal mucosa. | 2015 | Details |
| A20167 | 26114180 | J Gastrointestin Liver Dis | Non-invasive distinction of non-alcoholic fatty liver disease using urinary volatile organic compound analysis: early results. | 2015 | Details |
| A20169 | 26113985 | Open Heart | Capsaicin may have important potential for promoting vascular and metabolic health. | 2015 | Details |
| A20188 | 26097546 | Int J Clin Exp Pathol | Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease. | 2015 | Details |
| A20190 | 26094890 | Cell Metab | Jejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling. | 2015 | Details |
| A20194 | 26090468 | Biomed Res Int | Gut Microbiota: Association with NAFLD and Metabolic Disturbances. | 2015 | Details |
| A20213 | 26080824 | Zhonghua Nei Ke Za Zhi | [Myosin light chain kinase involved in change of intestinal mucosal barrier function in nonalcoholic steatohepatitis mice model]. | 2015 | Details |
| A20222 | 26078557 | World J Gastroenterol | What are the effects of proton pump inhibitors on the small intestine? | 2015 | Details |
| A20237 | 26070860 | Expert Rev Gastroenterol Hepatol | Physiology and pathophysiology of liver lipid metabolism. | 2015 | Details |
| A20240 | 26069285 | Thorax | Altered gut-liver axis and hepatic adiponectin expression in OSAS: novel mediators of liver injury in paediatric non-alcoholic fatty liver. | 2015 | Details |
| A20241 | 26067771 | Hepatol Int | The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation. | 2015 | Details |
| A20261 | 26058319 | Liver Int | Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure. | 2015 | Details |
| A20272 | 26052375 | World J Hepatol | Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets. | 2015 | Details |
| A20289 | 26045268 | Dig Dis | Relationship between Obesity, Gut Microbiome and Hepatocellular Carcinoma Development. | 2015 | Details |
| A20330 | 26026390 | Gastroenterology | High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery. | 2015 | Details |
| A20349 | 26019445 | World J Gastroenterol | Liver involvement in pediatric celiac disease. | 2015 | Details |
| A20350 | 26019443 | World J Gastroenterol | Pathophysiology after pancreaticoduodenectomy. | 2015 | Details |
| A20370 | 26006114 | Gut | Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease. | 2015 | Details |
| A20393 | 25994073 | Diabetologia | Incretin-based therapies: where will we be 50 years from now? | 2015 | Details |
| A20397 | 25993337 | PLoS One | Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis. | 2015 | Details |
| A20404 | 25988562 | J Pediatr Gastroenterol Nutr | Omega-3 Fatty Acid-Rich Parenteral Nutrition: Is It a Double-Edged Sword? | 2015 | Details |
| A20449 | 25956735 | Med Hypotheses | Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? - A mechanistic hypothesis. | 2015 | Details |
| A20471 | 25940690 | Food Funct | Salicylic acid elicitation during cultivation of the peppermint plant improves anti-diabetic effects of its infusions. | 2015 | Details |
| A20483 | 25934114 | Nutr Res | Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model. | 2015 | Details |
| A20503 | 25919774 | Eur J Gastroenterol Hepatol | Bariatric surgery and nonalcoholic fatty liver disease. | 2015 | Details |
| A20534 | 25906652 | Lik Sprava | [State of intestinal microbiota in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease]. | 2015 | Details |
| A20543 | 25904096 | J Gastroenterol | Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy. | 2015 | Details |
| A20551 | 25892944 | Malays J Med Sci | What is Obesity Doing to Your Gut? | 2015 | Details |
| A20557 | 25889212 | J Transl Med | Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach? | 2015 | Details |
| A20563 | 25882223 | Curr Drug Targets | Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A20586 | 25870102 | Drug Metab Dispos | Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics. | 2015 | Details |
| A20621 | 25848479 | World J Hepatol | Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. | 2015 | Details |
| A20756 | 25753988 | Hepatology | Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis. | 2015 | Details |
| A20787 | 25736031 | Clin Nutr | Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. | 2015 | Details |
| A20840 | 25697178 | Br J Nutr | Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. | 2015 | Details |
| A20854 | 25684933 | World J Gastroenterol | Gut microbiota and liver diseases. | 2015 | Details |
| A20858 | 25683343 | Diabet Med | Practical approach to non-alcoholic fatty liver disease in patients with diabetes. | 2015 | Details |
| A20890 | 25659874 | Atheroscler Suppl | The effect of ezetimibe on NAFLD. | 2015 | Details |
| A20898 | 25655287 | Hepatobiliary Pancreat Dis Int | Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases. | 2015 | Details |
| A20903 | 25654290 | Zhonghua Gan Zang Bing Za Zhi | [Association of intestinal epithelial tight junctions, E.coli, intestinal mucosa Toll-like receptor-4 and tumor necrosis factor-alpha in rabbit with non-alcoholic fatty liver disease]. | 2014 | Details |
| A20921 | 25644696 | Sci Rep | Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. | 2015 | Details |
| A20958 | 25617505 | J Hepatol | Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease. | 2015 | Details |
| A20966 | 25614396 | J Ultrasound Med | Spleen size in cirrhosis of different etiologies. | 2015 | Details |
| A21024 | 25568861 | Hepatobiliary Surg Nutr | Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease. | 2014 | Details |
| A21035 | 25563215 | Eur J Pediatr | The intestinal microbiota: its role in health and disease. | 2015 | Details |
| A21051 | 25553772 | Expert Opin Drug Metab Toxicol | Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility. | 2015 | Details |
| A21062 | 27682116 | Microorganisms | Gut Microbiota and Host Reaction in Liver Diseases. | 2015 | Details |
| A21073 | 26931009 | Eksp Klin Gastroenterol | [CLINICAL FEATURE OF NONALCOHOLIC STEATOHEPATITIS, ASSOCIATED WITH CHRONIC CONSTIPATION]. | 2015 | Details |
| A21079 | 25548472 | World J Gastroenterol | Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. | 2014 | Details |
| A21147 | 25514915 | Rev Recent Clin Trials | Treatment strategies for fatty liver diseases. | 2014 | Details |
| A21151 | 25514911 | Rev Recent Clin Trials | Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis. | 2014 | Details |
| A21171 | 25502558 | PLoS One | A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet. | 2014 | Details |
| A21174 | 25500885 | J Clin Invest | Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. | 2014 | Details |
| A21185 | 25493023 | World J Gastroenterol | Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease. | 2014 | Details |
| A21200 | 25482832 | Hepatology | Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). | 2015 | Details |
| A21205 | 25479248 | Nutrients | The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
| A21217 | 25473159 | World J Gastroenterol | Gut microbiota and metabolic syndrome. | 2014 | Details |
| A21226 | 25469019 | World J Gastroenterol | Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. | 2014 | Details |
| A21228 | 25469014 | World J Gastroenterol | Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. | 2014 | Details |
| A21229 | 25469013 | World J Gastroenterol | Obesity, fatty liver disease and intestinal microbiota. | 2014 | Details |
| A21284 | 27356366 | Bull Acad Natl Med | [Not Available]. | 2014 | Details |
| A21294 | 25428903 | Am J Physiol Gastrointest Liver Physiol | Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model. | 2014 | Details |
| A21297 | 25427048 | J Cardiovasc Med (Hagerstown) | Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? | 2015 | Details |
| A21303 | 25421042 | Mol Med Rep | Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. | 2014 | Details |
| A21310 | 25414939 | Postgrad Med | Diabetes mellitus as a novel risk factor for gastrointestinal malignancies. | 2014 | Details |
| A21333 | 25400436 | World J Gastroenterol | Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. | 2014 | Details |
| A21359 | 25378958 | Hepat Med | Surgical treatment of nonalcoholic fatty liver disease in severely obese patients. | 2014 | Details |
| A21392 | 25352725 | Bioinformation | Data from a randomized and controlled trial of LCarnitine prescription for the treatment for Non- Alcoholic Fatty Liver Disease. | 2014 | Details |
| A21407 | 25345094 | Pediatr Endocrinol Rev | Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases. | 2014 | Details |
| A21449 | 25310763 | Pediatr Res | Gut microbiome and nonalcoholic fatty liver diseases. | 2014 | Details |
| A21471 | 25296089 | Arq Gastroenterol | Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study. | 2015 | Details |
| A21495 | 25278690 | World J Gastroenterol | Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. | 2014 | Details |
| A21563 | 25225347 | Adv Nutr | Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. | 2014 | Details |
| A21579 | 25215659 | Nutrients | Obesity as an emerging risk factor for iron deficiency. | 2014 | Details |
| A21602 | 25194181 | Best Pract Res Clin Gastroenterol | Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. | 2014 | Details |
| A21603 | 25194178 | Best Pract Res Clin Gastroenterol | Mechanisms behind the link between obesity and gastrointestinal cancers. | 2014 | Details |
| A21626 | 30736212 | Expert Rev Endocrinol Metab | Non-alcoholic fatty liver disease in patients with diabetes mellitus. | 2014 | Details |
| A21645 | 25156247 | Liver Int | Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal. | 2014 | Details |
| A21651 | 25152979 | Ann Hepatol | Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients. | 2015 | Details |
| A21725 | 25089585 | Br J Nutr | Beneficial effects of heat-treated Enterococcus faecalis FK-23 on high-fat diet-induced hepatic steatosis in mice. | 2014 | Details |
| A21741 | 25080921 | Toxicol Sci | Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis. | 2014 | Details |
| A21750 | 25072743 | J Med Food | Functional and metabolic disorders in celiac disease: new implications for nutritional treatment. | 2014 | Details |
| A21755 | 25069836 | Eat Weight Disord | The therapy of insulin resistance in other diseases besides type 2 diabetes. | 2014 | Details |
| A21762 | 25063410 | J Ultrasound Med | Focal fatty sparing usually does not arise in preexisting nonalcoholic diffuse homogeneous fatty liver. | 2014 | Details |
| A21785 | 25045618 | Curr Hepatol Rep | Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis. | 2014 | Details |
| A21791 | 25043514 | Hepatology | Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. | 2014 | Details |
| A21840 | 25009406 | World J Gastroenterol | Hemorrhagic ascites from spontaneous ectopic mesenteric varices rupture in NASH induced cirrhosis and successful outcome: a case report. | 2014 | Details |
| A21847 | 25003671 | Turk J Gastroenterol | Role of gut microbiota: obesity and NAFLD. | 2014 | Details |